Join us next week at the Goldman Sachs Global Healthcare Conference on June 12th at 4:00 PM ET to hear the latest corporate updates from our CEO, Dr. Will Chou. Secure your spot and register for the webcast today! loom.ly/pISWesY

We are proud to sponsor the Philadelphia Million Dollar Bike Ride, an annual event in our hometown that has channeled over $17 million into rare disease research. Learn more about this special event, coming up this Saturday, here: loom.ly/6I1gXvI #PennMedMDBR2024

Passage Bio recognizes Juneteenth as a critical day in our history. To emphasize the ongoing journey toward equality and justice, our employees will have the day off to engage in personal reflection, education, and celebration. #Juneteenth2023 #CelebrateFreedom

Last week, our team had an unforgettable summer team-building event at Grounds for Sculpture. With colleagues spread across different locations, we truly value the time we can spend together!

As Alzheimer's & Brain Awareness Month comes to a close, we reflect on our commitment to advance gene therapies that have the potential to change the lives of patients and their families with neurodegenerative conditions. Learn more here: loom.ly/WkGeVEQ #ENDALZ

Happy Independence Day from Passage Bio! Today, we honor the spirit of freedom and innovation that defines our nation.

Our CEO Will Chou, MD, recently joined the Life Science Success Podcast. Tune in for insights here: loom.ly/XCh2t9E #LifeScienceSuccess

We are thrilled to share that Passage Bio has received positive feedback from the FDA on expanding our upliFT-D trial of PBFT02 to include patients with frontotemporal dementia (#FTD) due to C9orf72 gene mutations. Read more here: passagebio.com/investors-and-…

If you or a loved one has #FTD, genetic counseling and testing are essential. It can pinpoint if a mutation caused your FTD, provide insights into your symptoms, and identify clinical trial eligibility, such as the upliFT-D trial for FTD-GRN. Learn more: loom.ly/hm5g0lc

Passage Bio will be participating in the Canaccord Genuity 44th Annual Growth Conference in Boston on August 13 and the 15th Annual Wedbush PacGrow Healthcare Conference in New York City on August 14. Learn more here: loom.ly/NQfz__U

This morning, we announced our second quarter 2024 #financialresults and recent #business highlights. Learn more about our latest achievements and upcoming milestones here: loom.ly/HxgqpDQ

ICYMI: @Biotech TV recently joined us at our Philadelphia HQ to discuss our groundbreaking work in treating #FTD. Watch the full video to learn about what's on the horizon for Passage Bio here: loom.ly/4KgAgjc

DYK: progranulin is vital for brain cell health, and increasing its levels could benefit patients with both FTD-C9orf72 and FTD-GRN? We are expanding our upliFT-D trial to include individuals with C9orf72 gene mutations. Learn more about this news here: loom.ly/qMRn2rw

Passage Bio will be at the H.C. Wainwright 26th Annual Global Investment Conference next week on September 9! Register to hear the latest company updates directly from Will Chou, M.D., CEO during our corporate presentation: loom.ly/pljNXRs